Organization | The Danish Council for Strategic Research

The Danish Council for Strategic Research Report issue

Government Phase 1

Founded: Copenhagen Denmark (2004)

Organization Overview

First Clinical Trial

2004

NCT01353807

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

The Danish Council for Strategic Research

Active Ingredients

Drugs in Phase 1 Trials (1)

acetylcysteine (mucomyst) (1 trial)

Drugs in Other Trials (10)

bifidobacterium animalis (2 trials)

fish oil (Omegavan) (1 trial)

glucoraphanin (1 trial)

high-selenium yeast (1 trial)

insulin lispro (humalog) (1 trial)

lactobacillus rhamnosus (1 trial)

olive oil (1 trial)

soy protein (1 trial)

trebananib (1 trial)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chemical and Drug Induced Liver Injury (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 10
# of Trial APIs: 11